AAAAAA

   
Results: 1-14 |
Results: 14
PREVENTION OF VASCULAR THROMBOSIS IN DOGS BY THE ACTIVE METABOLITE OFORBOFIBAN
Authors: SZALONY JA TAITE BB FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS
Citation: Ja. Szalony et al., PREVENTION OF VASCULAR THROMBOSIS IN DOGS BY THE ACTIVE METABOLITE OFORBOFIBAN, The FASEB journal, 12(5), 1998, pp. 4175-4175
PROTECTIVE EFFECT OF ORAL XEMILOFIBAN IN ARTERIAL THROMBOSIS IN DOGS - INCREASED ACTIVITY IN COMBINATION WITH ASPIRIN
Authors: FREDERICK LG SULEYMANOV OD SZALONY JA TAITE BB SALYERS AK KING LW FEIGEN LP NICHOLSON NS
Citation: Lg. Frederick et al., PROTECTIVE EFFECT OF ORAL XEMILOFIBAN IN ARTERIAL THROMBOSIS IN DOGS - INCREASED ACTIVITY IN COMBINATION WITH ASPIRIN, Circulation, 98(8), 1998, pp. 813-820
THE PROTECTIVE DOSE OF THE POTENT GPIIB IIIA ANTAGONIST SC-54701A IS REDUCED WHEN USED IN COMBINATION WITH ASPIRIN AND HEPARIN IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS/
Authors: FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS FEIGEN LP
Citation: Lg. Frederick et al., THE PROTECTIVE DOSE OF THE POTENT GPIIB IIIA ANTAGONIST SC-54701A IS REDUCED WHEN USED IN COMBINATION WITH ASPIRIN AND HEPARIN IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS/, Circulation, 93(1), 1996, pp. 129-134
AEROBIC BIODEGRADATION OF SYNTHETIC AND NATURAL POLYMERIC MATERIALS -A COMPONENT OF INTEGRATED SOLID-WASTE MANAGEMENT
Authors: PETTIGREW CA RECE GA SMITH MC KING LW
Citation: Ca. Pettigrew et al., AEROBIC BIODEGRADATION OF SYNTHETIC AND NATURAL POLYMERIC MATERIALS -A COMPONENT OF INTEGRATED SOLID-WASTE MANAGEMENT, Journal of macromolecular science. Pure and applied chemistry, A32(4), 1995, pp. 811-821
ANTITHROMBOTIC EFFECTS OF SC-54701A (SCA) IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
Authors: FREDERICK LG SULEYMANOV OD KING LW SALYERS AK NICHOLSON NS FEIGEN LP
Citation: Lg. Frederick et al., ANTITHROMBOTIC EFFECTS OF SC-54701A (SCA) IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS, The FASEB journal, 9(3), 1995, pp. 55-55
ASPIRIN LOWERS THE EFFECTIVE DOSE OF A GP IIB IIIA ANTAGONIST IN A DOG-MODEL OF CORONARY-THROMBOSIS/
Authors: FEIGEN LP FREDERICK LG KING LW SULEYMANOV OD NICHOLSON NS
Citation: Lp. Feigen et al., ASPIRIN LOWERS THE EFFECTIVE DOSE OF A GP IIB IIIA ANTAGONIST IN A DOG-MODEL OF CORONARY-THROMBOSIS/, Thrombosis and haemostasis, 73(6), 1995, pp. 1333-1333
POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS
Authors: ZABLOCKI JA RICO JG GARLAND RB ROGERS TE WILLIAMS K SCHRETZMAN LA RAO SA BOVY PR TJOENG FS LINDMARK RJ TOTH MV ZUPEC ME MCMACKINS DE ADAMS SP MIYANO M MARKOS CS MILTON MN PAULSON S HERIN M JACQMIN P NICHOLSON NS PANZERKNODLE SG HAAS NF PAGE JD SZALONY JA TAITE BB SALYERS AK KING LW CAMPION JG FEIGEN LP
Citation: Ja. Zablocki et al., POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 38(13), 1995, pp. 2378-2394
SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION
Authors: NICHOLSON NS PANZERKNODLE SG SALYERS AK TAITE BB SZALONY JA HAAS NF KING LW ZABLOCKI JA KELLER BT BROSCHAT K ENGLEMAN VW HERIN M JACQMIN P FEIGEN LP
Citation: Ns. Nicholson et al., SC-54684A - AN ORALLY-ACTIVE INHIBITOR OF PLATELET-AGGREGATION, Circulation, 91(2), 1995, pp. 403-410
CHARACTERIZATION OF COMPOST FROM A PILOT PLANT-SCALE COMPOSTER UTILIZING SIMULATED SOLID-WASTE
Authors: SCHWAB BS RITCHIE CJ KAIN DJ DOBRIN GC KING LW PALMISANO AC
Citation: Bs. Schwab et al., CHARACTERIZATION OF COMPOST FROM A PILOT PLANT-SCALE COMPOSTER UTILIZING SIMULATED SOLID-WASTE, Waste management and research, 12(4), 1994, pp. 289-303
SC-49992 - A POTENT AND SPECIFIC INHIBITOR OF PLATELET-AGGREGATION
Authors: NICHOLSON NS PANZERKNODLE SG KING LW TAITE BB KELLER BT TJOENG FS ENGLEMAN VW GIORGIO TD FEIGEN LP
Citation: Ns. Nicholson et al., SC-49992 - A POTENT AND SPECIFIC INHIBITOR OF PLATELET-AGGREGATION, Thrombosis research, 74(5), 1994, pp. 523-535
DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE
Authors: NICHOLSON NS HAAS NF TAITE BB PANZERKNODLE SG KING LW ABOOD NA ZABLOCKI JA RICO JG SMITH JW FEIGEN LP
Citation: Ns. Nicholson et al., DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE, Circulation, 90(4), 1994, pp. 181-181
DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE
Authors: NICHOLSON NS HAAS NF TAITE BB PANZERKNODLE SG KING LW ABOOD NA ZABLOCKI JA RICO JG SMITH JW FEIGEN LP
Citation: Ns. Nicholson et al., DISPARATE EFFECTS OF FIBRINOGEN RECEPTOR ANTAGONISTS ON PLATELET-AGGREGATION, BLEEDING-TIME, CLOT RETRACTION AND EXPRESSION OF ALPHA-IIB-BETA-3 LIBS EPITOPE, Circulation, 90(4), 1994, pp. 181-181
SC-49992, A MIMETIC OF THE PEPTIDE ARGININE-GLYCINE-ASPARTIC ACID-PHENYLALANINE THAT BLOCKS PLATELET-AGGREGATION, ENHANCES RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR-INDUCED THROMBOLYSIS AND PREVENTS REOCCLUSIONIN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
Authors: FEIGEN LP NICHOLSON NS KING LW CAMPION JG TJOENG FS PANZERKNODLE SG
Citation: Lp. Feigen et al., SC-49992, A MIMETIC OF THE PEPTIDE ARGININE-GLYCINE-ASPARTIC ACID-PHENYLALANINE THAT BLOCKS PLATELET-AGGREGATION, ENHANCES RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR-INDUCED THROMBOLYSIS AND PREVENTS REOCCLUSIONIN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1191-1197
POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP-PHE SEQUENCE OF FIBRINOGEN - A PROPOSAL ON THE NATURE OF THE BINDING INTERACTION BETWEEN THE ARG-GUANIDINE OF RGDX MIMETICS AND THE PLATELET GP IIB-IIIA RECEPTOR
Authors: ZABLOCKI JA MIYANO M GARLAND RB PIREH D SCHRETZMAN L RAO SN LINDMARK RJ PANZERKNODLE SG NICHOLSON NS TAITE BB SALYERS AK KING LW CAMPION JG FEIGEN LP
Citation: Ja. Zablocki et al., POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP-PHE SEQUENCE OF FIBRINOGEN - A PROPOSAL ON THE NATURE OF THE BINDING INTERACTION BETWEEN THE ARG-GUANIDINE OF RGDX MIMETICS AND THE PLATELET GP IIB-IIIA RECEPTOR, Journal of medicinal chemistry, 36(13), 1993, pp. 1811-1819
Risultati: 1-14 |